Japan-based Eisai and FUJI YAKUHIN have inked a license agreement concerning dotinurad (generic name), a treatment for h...
Mutant DNA sequences inside cellular mitochondria can be eliminated using a bespoke chemical compound. The approach, dev...
Shimadzu has released the SARS-CoV-2 Mutation Assay Core Kit, Primer/Probe Mix for N501Y, Primer/Probe Mix for L452R, an...
Cryoport, a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences inc...
Japan-based NEC has signed a joint research agreement with Teikyo University, and Mizonokuchi Hospital to vis...
Japan's Tohoku University researchers have developed a new analytical method that visualizes cell functions in MPS using...
Shimadzu Corporation and HORIBA have released a new LC-Raman system that combines a Shimadzu high-performance liquid chr...
In response to the COVID-19 pandemic and the rise of digital consumption patterns, as well as assist companies in their ...
Fujifilm Corporation has announced its AI-powered product for analyzing chest X-ray 'CXR-AID' will be commercially avail...
U.S. Food and Drug Administration (FDA) has approved a combination therapy from Eisai and Merck (MSD) namely,&...
A cross-sectional study was recently conducted to clarify the adverse events of COVID-19 vaccines in Japanese young popu...
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...
Otsuka Pharmaceutical Development & Commercialization, Inc., a subsidiary of Japan-based Otsuka Pharmaceutical, has ...
KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmac...
Telix Pharmaceuticals Limited announced that Mr. Ryoichi Tanaka has joined the Telix Japan leadership team in the role o...
In a new study, a multi-national effort that included researchers at the Institute for Advanced Study of Biology (ASHBi)...
Japan-based Chugai Pharmaceutical has launched FoundationOne Liquid CDx Cancer Genomic Profile as a liquid biopsy-based ...
Japanese pharmaceutical company Takeda and US-based Frazier Healthcare Partners have announced a collaboration to l...
